Exelixis financial statements

Name: Quantus Signal — KR/US technical signal dataset
License: https://www.quantus.kr/signal/terms

엑셀릭시스NASDAQ:EXEL · Nasdaq · Healthcare

$58.39+0.78%

2026-10-02 close

Exelixis's published financial data is dated 2026-10-04. 2025 revenue was $2.17B. 2025 operating profit was $605M.

Reported results

Quantus Signal · live data · not investment advice · Privacy Policy